TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

31.90$ -2.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Parabilis Medicines, Inc. (PBLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -124 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PBLS
Line item 2024 2025
-104 -124
2.1 2.5
4.3 3.3
0.9 9.1
0.9 0.3
30 40
-0.5 -0.1
0.0 -3.1
78 64
4.7 -20
-104 -124

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?